Csenge Advisory Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Csenge Advisory Group’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-60	Closed	-$2K	–	1610
2018 Q3	$2K	Buy	+60	New	+$2.94K	﹤0.01%	804

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Csenge Advisory Group's SYNH Position: Q4 2018 in Review

Csenge Advisory Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2018, closing a stake of 60 shares — an estimated $2K sold.

Csenge Advisory Group first reported a position in SYNH in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 257 funds tracked by Wall St. Rank hold SYNH as of Q4 2018.

Csenge Advisory Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 60 Syneos Health, Inc. Class A Common Stock shares in Q4 2018, an estimated $2K.
Csenge Advisory Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Syneos Health, Inc. Class A Common Stock position peaked at $2K in Q3 2018.
257 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.